Is BPC 157 Legal? Understanding Its Status and Implications BPC 157 and TB 500: Uses and Safety ConsumerLab.com The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives Analysis: The peptide problem: Hype is outrunning the evidence McMaster News